EURAZEO

Eurazeo SE occupies a category of European capital markets that is frequently misunderstood. It is simultaneously a balance sheet investor holding minority and majority stakes in private companies, and a third-party asset manager collecting fees on capital committed by insurers, pension funds, and family offices. The market tends to price it as the former while management increasingly runs it as the latter. This gap between how Eurazeo is valued and how Eurazeo is operated defines the central analytical tension of the company in 2026.

The raw data reveals a firm in apparent distress. Reported net income of negative EUR 404 million in 2025 followed a negative EUR 430 million figure in 2024. Revenue collapsed from EUR 5.59 billion in 2022 to EUR 468 million in 2025, a sequence that would destroy most companies. Yet Eurazeo simultaneously returned EUR 571 million to shareholders in 2025 through dividends and buybacks, reduced share count materially, and saw analysts project a return to EUR 475 million in net income by 2028. Something in this picture does not match the standard industrial playbook.

The central L17X observation is this: Eurazeo is not a company whose revenue line means what revenue lines usually mean. The EUR 5.6 billion figure from 2022 was consolidated portfolio company revenue under IFRS 10. The EUR 468 million figure from 2025 reflects a deconsolidated asset management operator plus investment income. The net losses are not operating losses, they are accounting translations of portfolio value changes in a compressed private asset market. The real question is whether the third-party asset management franchise can grow fast enough to justify a balance sheet discount that has persisted for a decade.

Current price around EUR 44.50 against reported book value per share near EUR 99.50 implies the market is pricing Eurazeo's NAV at roughly 55 percent of its stated value. For a balance sheet of private assets whose marks are determined by internal valuation committees and external audit review, this discount is either an opportunity or a warning. The analytical challenge is identifying which.